{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T16:41:21Z","timestamp":1649176881697},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jdiacomp.2009.07.002","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T16:43:37Z","timestamp":1253897017000},"page":"63-72","source":"Crossref","is-referenced-by-count":0,"title":["Concept paper: antihyperglycemic therapy and the diabetic heart\u2014do we really know enough?"],"prefix":"10.1016","volume":"25","author":[{"given":"Jerzy W.","family":"Kolaczynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jdiacomp.2009.07.002_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.157.2.181","article-title":"Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs cooperative study on glycemic control and complications in Type II diabetes","volume":"157","author":"Abraira","year":"1997","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.jdiacomp.2009.07.002_bb0010","first-page":"S3","article-title":"Summary of revisions for the 2009 Clinical Practice Recommendations","volume":"32","author":"ADA","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jdiacomp.2009.07.002_bb0015","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","article-title":"Role of changes in cardiac metabolism in development of diabetic cardiomyopathy","volume":"291","author":"An","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"2","key":"10.1016\/j.jdiacomp.2009.07.002_bb0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1172\/JCI100504","article-title":"On diabetic acidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy","volume":"12","author":"Atchley","year":"1933","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.jdiacomp.2009.07.002_bb0025","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1210\/en.136.6.2547","article-title":"Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride","volume":"136","author":"Bahr","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2009.07.002_bb0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.abb.2008.05.015","article-title":"Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability","volume":"477","author":"Baranowski","year":"2008","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.07.002_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/db06-0481","article-title":"Combined use of rosiglitazone and fenofibrate in patients with Type 2 diabetes: prevention of fluid retention","volume":"56","author":"Boden","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jdiacomp.2009.07.002_bb0040","doi-asserted-by":"crossref","first-page":"H1538","DOI":"10.1152\/ajpheart.00281.2004","article-title":"Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation","volume":"287","author":"Chandler","year":"2004","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.07.002_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.HYP.0000047668.48494.39","article-title":"Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease","volume":"41","author":"de las Fuentes","year":"2003","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.jdiacomp.2009.07.002_bb0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI107996","article-title":"The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man","volume":"55","author":"DeFronzo","year":"1975","journal-title":"Journal of Clinical Investigation"},{"issue":"9493","key":"10.1016\/j.jdiacomp.2009.07.002_bb0055","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with Type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jdiacomp.2009.07.002_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with Type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"Pt 1","key":"10.1016\/j.jdiacomp.2009.07.002_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","article-title":"AMPK alterations in cardiac physiology and pathology: enemy or ally?","volume":"574","author":"Dyck","year":"2006","journal-title":"Journal of Physiology"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.07.002_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.jdiacomp.2009.07.002_bb0075","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in Type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"9153","key":"10.1016\/j.jdiacomp.2009.07.002_bb0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with Type 2 diabetes mellitus and microalbuminuria: the Steno Type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jdiacomp.2009.07.002_bb0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1016\/j.jdiacomp.2009.07.002_bb0090","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in Type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.jdiacomp.2009.07.002_bb0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10557-006-0582-8","article-title":"Regulation of sarcolemmal transport of substrates in the healthy and diseased heart","volume":"20","author":"Glatz","year":"2006","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"8","key":"10.1016\/j.jdiacomp.2009.07.002_bb0100","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm1278","article-title":"Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption","volume":"11","author":"Guan","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jdiacomp.2009.07.002_bb0105","article-title":"ADVANCE, VADT, and ACCORD: Why such a discrepant effect from a reduction in HbA1c to near-normal levels?","author":"Guillausseau","year":"2008","journal-title":"International Journal of Metabolism"},{"issue":"12","key":"10.1016\/j.jdiacomp.2009.07.002_bb0110","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1464-5491.2004.01332.x","article-title":"Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone","volume":"21","author":"Hallsten","year":"2004","journal-title":"Diabet Med"},{"issue":"13","key":"10.1016\/j.jdiacomp.2009.07.002_bb0115","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1016\/j.jdiacomp.2009.07.002_bb0120","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in Type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.07.002_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa073394","article-title":"Rosiglitazone evaluated for cardiovascular outcomes\u2014an interim analysis","volume":"357","author":"Home","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.jdiacomp.2009.07.002_bb0130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diacare.16.7.1026","article-title":"Effective treatment of insulin-induced edema using ephedrine","volume":"16","author":"Hopkins","year":"1993","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jdiacomp.2009.07.002_bb0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI24405","article-title":"Mitochondrial energy metabolism in heart failure: a question of balance","volume":"115","author":"Huss","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/j.jdiacomp.2009.07.002_bb0140","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.2337\/diabetes.51.10.3020","article-title":"Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance","volume":"51","author":"Iozzo","year":"2002","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.jdiacomp.2009.07.002_bb0145","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/01.CIR.103.13.1734","article-title":"Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease","volume":"103","author":"Jagasia","year":"2001","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jdiacomp.2009.07.002_bb0150","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"Pt 2","key":"10.1016\/j.jdiacomp.2009.07.002_bb0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1113\/jphysiol.2002.018135","article-title":"Myocardial and skeletal muscle glucose uptake during exercise in humans","volume":"542","author":"Kemppainen","year":"2002","journal-title":"Journal of Physiology"},{"issue":"4","key":"10.1016\/j.jdiacomp.2009.07.002_bb0160","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1067\/S0022-3476(03)00414-1","article-title":"Cardiac failure after initiation of insulin treatment in diabetic patients with beta-thalassemia major","volume":"143","author":"Konrad","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1016\/j.jdiacomp.2009.07.002_bb0165","doi-asserted-by":"crossref","first-page":"H1345","DOI":"10.1152\/ajpheart.2000.278.4.H1345","article-title":"Myocardial substrate metabolism influences left ventricular energetics in vivo","volume":"278","author":"Korvald","year":"2000","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"9578","key":"10.1016\/j.jdiacomp.2009.07.002_bb0170","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0140-6736(07)60824-1","article-title":"Cardiovascular safety of rosiglitazone","volume":"369","author":"Krall","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jdiacomp.2009.07.002_bb0175","first-page":"H313","article-title":"Effect of tolbutamide on myocardial energy metabolism","volume":"245","author":"Kramer","year":"1983","journal-title":"American Journal of Physiology"},{"issue":"5","key":"10.1016\/j.jdiacomp.2009.07.002_bb0180","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.fjc.0000159045.35241.95","article-title":"Effects of KATP channel modulation on myocardial glycogen content, lactate, and amino acids in nonischemic and ischemic rat hearts","volume":"45","author":"Kristiansen","year":"2005","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.07.002_bb0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.106.116871","article-title":"Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure","volume":"321","author":"Labinskyy","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/j.jdiacomp.2009.07.002_bb0190","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","article-title":"Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes","volume":"291","author":"Lautamaki","year":"2006","journal-title":"American Journal of Physiology, Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/j.jdiacomp.2009.07.002_bb0195","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with Type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"Journal of the American Medical Association"},{"issue":"Suppl","key":"10.1016\/j.jdiacomp.2009.07.002_bb0200","first-page":"789","article-title":"A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results","volume":"19","author":"Meinert","year":"1970","journal-title":"Diabetes"},{"issue":"24","key":"10.1016\/j.jdiacomp.2009.07.002_bb0205","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1016\/j.jdiacomp.2009.07.002_bb0210","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.294.20.joc50147","article-title":"Effect of muraglitazar on death and major adverse cardiovascular events in patients with Type 2 diabetes mellitus","volume":"294","author":"Nissen","year":"2005","journal-title":"Journal of the American Medical Association"},{"issue":"5","key":"10.1016\/j.jdiacomp.2009.07.002_bb0215","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1172\/JCI117226","article-title":"Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle","volume":"93","author":"Nuutila","year":"1994","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.jdiacomp.2009.07.002_bb0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0026-0495(94)90241-0","article-title":"Total-body and myocardial substrate oxidation in congestive heart failure","volume":"43","author":"Paolisso","year":"1994","journal-title":"Metabolism"},{"issue":"24","key":"10.1016\/j.jdiacomp.2009.07.002_bb0225","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with Type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"7285","key":"10.1016\/j.jdiacomp.2009.07.002_bb0230","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jdiacomp.2009.07.002_bb0235","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2337\/dc08-0167","article-title":"Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies","volume":"31","author":"Rao","year":"2008","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.jdiacomp.2009.07.002_bb0240","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/hc4901.100526","article-title":"Metabolic gene expression in fetal and failing human heart","volume":"104","author":"Razeghi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2009.07.002_bb0245","first-page":"92","article-title":"How free fatty acids inhibit glucose utilization in human skeletal muscle","volume":"19","author":"Roden","year":"2004","journal-title":"News News in Physiological Sciences"},{"issue":"6","key":"10.1016\/j.jdiacomp.2009.07.002_bb0250","doi-asserted-by":"crossref","first-page":"H2497","DOI":"10.1152\/ajpheart.00873.2007","article-title":"Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms","volume":"294","author":"Saeedi","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"3B","key":"10.1016\/j.jdiacomp.2009.07.002_bb0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9343(85)80007-3","article-title":"Effect of glyburide on myocardial metabolism and function","volume":"79","author":"Schaffer","year":"1985","journal-title":"American Journal of Medicine"},{"issue":"8","key":"10.1016\/j.jdiacomp.2009.07.002_bb0260","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0805-822","article-title":"TZDs and diabetes: testing the waters","volume":"11","author":"Semenkovich","year":"2005","journal-title":"Nature Medicine"},{"issue":"10","key":"10.1016\/j.jdiacomp.2009.07.002_bb0265","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI30335","article-title":"Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice","volume":"117","author":"Son","year":"2007","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.jdiacomp.2009.07.002_bb0270","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1210\/jc.2006-1416","article-title":"Impact of Type 2 diabetes on myocardial insulin sensitivity to glucose uptake and perfusion in patients with coronary artery disease","volume":"91","author":"Sondergaard","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.jdiacomp.2009.07.002_bb0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0008-6363(97)00047-3","article-title":"Regulation of energy substrate metabolism in the diabetic heart","volume":"34","author":"Stanley","year":"1997","journal-title":"Cardiovascular Research"},{"issue":"3","key":"10.1016\/j.jdiacomp.2009.07.002_bb0280","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiological Reviews"},{"issue":"14","key":"10.1016\/j.jdiacomp.2009.07.002_bb0285","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","article-title":"Adaptation and maladaptation of the heart in diabetes: Part I: general concepts","volume":"105","author":"Taegtmeyer","year":"2002","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.jdiacomp.2009.07.002_bb0290","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/CIRCULATIONAHA.106.645184","article-title":"Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure","volume":"114","author":"Tuunanen","year":"2006","journal-title":"Circulation"},{"issue":"9131","key":"10.1016\/j.jdiacomp.2009.07.002_bb0295","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UKPDS","year":"1998","journal-title":"Lancet"},{"issue":"9131","key":"10.1016\/j.jdiacomp.2009.07.002_bb0300","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UKPDS","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jdiacomp.2009.07.002_bb0305","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s001250050946","article-title":"Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM","volume":"41","author":"Utriainen","year":"1998","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jdiacomp.2009.07.002_bb0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU","volume":"354","author":"Van den Berghe","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1016\/j.jdiacomp.2009.07.002_bb0315","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.2337\/db06-0855","article-title":"Intensive insulin therapy in mixed medical\/surgical intensive care units: benefit versus harm","volume":"55","author":"Van den Berghe","year":"2006","journal-title":"Diabetes"},{"issue":"19","key":"10.1016\/j.jdiacomp.2009.07.002_bb0320","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in the critically ill patients","volume":"345","author":"Van den Berghe","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.jdiacomp.2009.07.002_bb0325","first-page":"1730","article-title":"Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction","volume":"42","author":"Vitale","year":"2001","journal-title":"Journal of Nuclear Medicine"},{"issue":"5","key":"10.1016\/j.jdiacomp.2009.07.002_bb0330","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1464-5491.1985.tb00663.x","article-title":"Insulin oedema and its clinical significance: metabolic studies in three cases","volume":"2","author":"Wheatley","year":"1985","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.jdiacomp.2009.07.002_bb0335","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jama.300.8.933","article-title":"Benefits and risks of tight glucose control in critically ill adults: a meta-analysis","volume":"300","author":"Wiener","year":"2008","journal-title":"Journal of the American Medical Association"},{"issue":"9493","key":"10.1016\/j.jdiacomp.2009.07.002_bb0340","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(05)67504-6","article-title":"The PROactive study: some answers, many questions","volume":"366","author":"Yki-Jarvinen","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jdiacomp.2009.07.002_bb0345","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00259-005-0042-x","article-title":"Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs","volume":"33","author":"Yokoyama","year":"2006","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"7","key":"10.1016\/j.jdiacomp.2009.07.002_bb0350","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2174\/1381612053381800","article-title":"Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders","volume":"11","author":"Yoshinaga","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"15","key":"10.1016\/j.jdiacomp.2009.07.002_bb0355","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/01.CIR.0000012467.61045.87","article-title":"Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms","volume":"105","author":"Young","year":"2002","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.jdiacomp.2009.07.002_bb0360","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0501744102","article-title":"Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention","volume":"102","author":"Zhang","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/j.jdiacomp.2009.07.002_bb0365","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"Journal of Clinical Investigation"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872709000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872709000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:12:48Z","timestamp":1558559568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872709000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1056872709000701"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2009.07.002","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}